🇺🇸 FDA
Pipeline program

DC-TC+GM-CSF

040420100005

Unknown mab completed

Quick answer

DC-TC+GM-CSF for Primary Hepatocellular Carcinoma is a Unknown program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Primary Hepatocellular Carcinoma
Phase
Unknown
Modality
mab
Status
completed

Clinical trials